Reversing FXa inhibitor activity in patients with acute major bleeding

Monday, May 22nd, 2023 | 11:00 AM - 12:00 PM CT

Every day, patients are hospitalized with a factor Xa (FXa) inhibitor-related acute major bleed. For those patients, every moment matters. Uncover the latest information on managing patients with FXa inhibitor-related acute major bleeding in this live discussion.

Learning Points:
 
  • The burden of life-threatening bleeds related to FXa Inhibitors
  • The rationale behind the reversal of anti-FXa activity
  • Clinical trials evaluating the efficacy and safety of FXa inhibitor reversal
  • Real world studies evaluating FXa inhibitor reversals 

Presenter: 

Paul Dobesh

Paul P. Dobesh, Pharm.D., FACC, FAHA, FCCP, BCPS, BCCP

Professor of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center

 

By registering, you agree to Becker's Healthcare terms of service and privacy policy.

I would like to also add the following learning opportunities to my registration:

  • Cut acute care delays & improve outcomes with an overlooked strategy: here. - April 8th at 11:00 AM CT - Learn Now
  • Expand cardiovascular care access now. Join Mount Sinai Health System and the American College Cardiology to learn how, here. - April 7th at 12:30 PM CT - Learn Now
  • What 'can't be stressed enough' in healthcare cybersecurity: here. - Read Now
  • This AI-payer pact saved a health system hundreds of hours. Learn how here. - Read Now
  • AdventHealth's 'best partnership' in the eyes of a top nurse exec here. - Read Now
  • Digital Innovation + Patient Experience + Marketing Virtual Event - Tuesday, August 5th, 2025 - Learn Now